Literature DB >> 27765543

The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac Events.

Ricardo Ladeiras-Lopes1, Francisco Sampaio2, Nuno Bettencourt3, Ricardo Fontes-Carvalho2, Nuno Ferreira2, Adelino Leite-Moreira3, Vasco Gama2.   

Abstract

INTRODUCTION AND
OBJECTIVES: Obesity is an important cardiovascular risk factor and the location of fat deposits seems to be an important determinant of its metabolic impact. Visceral adipose tissue (VAT) exerts a harmful effect on metabolic homeostasis, but few longitudinal studies have evaluated the prognostic impact of the ratio of VAT to subcutaneous adipose tissue (SAT). This study aimed to evaluate whether the VAT/SAT ratio was associated with all-cause mortality and cardiac events.
METHODS: Registry-based retrospective cohort study. Eligible patients consisted of those without known heart disease referred to cardiac computed tomography (CT) angiography to evaluate suspected coronary artery disease (CAD). We included all patients with available information on VAT and SAT areas and coronary artery calcium (CAC) score. We assessed the combined endpoint of all-cause mortality, myocardial infarction or revascularization procedure at least 1 month after cardiac CT.
RESULTS: The final population consisted of 713 participants (61% male; mean age, 57.7±10.2 years) followed up for a median of 1.3 years. The combined endpoint occurred in 66 patients; these patients showed a higher VAT/SAT ratio (1.06±0.74 vs 0.80±0.52, P=.0001). The VAT/SAT ratio was an independent predictor of death and cardiac events (HR = 1.43; 95%CI, 1.03-1.99), irrespective of cardiovascular risk factors, CAC, and the presence of CAD.
CONCLUSIONS: The ratio between abdominal VAT/SAT was an independent predictor of death and coronary events, irrespective of cardiovascular risk factors, CAC, and the presence of CAD. This ratio is a CT-derived metric that may help to better identify patients with increased risk of death or cardiac events.
Copyright © 2016 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Abdominal obesity; Cardiac computed tomography; Cardiovascular disease; Coronariografía por tomografía computarizada; Coronary artery disease; Enfermedad arterial coronaria; Enfermedad cardiovascular; Obesidad abdominal; Tejido adiposo visceral; Visceral adipose tissue

Mesh:

Year:  2016        PMID: 27765543     DOI: 10.1016/j.rec.2016.09.010

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  19 in total

1.  Response.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

2.  Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume?

Authors:  Yusuke Noumura; Tamotsu Kamishima; Kenneth Sutherland; Hideho Nishimura
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

3.  Fully automated segmentation and quantification of visceral and subcutaneous fat at abdominal CT: application to a longitudinal adult screening cohort.

Authors:  Scott J Lee; Jiamin Liu; Jianhua Yao; Andrew Kanarek; Ronald M Summers; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2018-03-28       Impact factor: 3.039

4.  Methylation of imprinted IGF2 regions is associated with total, visceral, and hepatic adiposity in postmenopausal women.

Authors:  Min-Ae Song; Thomas Ernst; Maarit Tiirikainen; Jörg Tost; Lynne R Wilkens; Linda Chang; Laurence N Kolonel; Loïc Le Marchand; Unhee Lim
Journal:  Epigenetics       Date:  2018-10-02       Impact factor: 4.528

5.  The role of visceral and subcutaneous adipose tissue measurements and their ratio by magnetic resonance imaging in subjects with prediabetes, diabetes and healthy controls from a general population without cardiovascular disease.

Authors:  Corinna Storz; Sophia D Heber; Susanne Rospleszcz; Jürgen Machann; Sabine Sellner; Konstantin Nikolaou; Roberto Lorbeer; Sergios Gatidis; Stefanie Elser; Annette Peters; Christopher L Schlett; Fabian Bamberg
Journal:  Br J Radiol       Date:  2018-02-19       Impact factor: 3.039

6.  Clinical Characteristics and Angiographic Findings of Myocardial Infarction among Marijuana Users and Non-Users.

Authors:  Justin Lee; Navneet Sharma; Carla Saladini Aponte; Seyed Zaidi; Daniel Fung; Jonathan D Marmur; Moro Salifu; Alyson Myers; William E Lawson; Noelle N Mann; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2017-11-22

7.  Clinical Characteristics and Angiographic Findings of Acute Myocardial Infarction Associated With Marijuana Use: Consecutive Case Series.

Authors:  Navneet Sharma; Justin Lee; Carla Saladini Aponte; Jonathan D Marmur; William E Lawson; Noelle N Mann; Moro O Salifu; Irini Youssef; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2017-11-22

8.  Correlations between the abdominal fat-related parameters and severity of coronary artery disease assessed by computed tomography.

Authors:  Yating Gao; Yuan-Cheng Wang; Chun-Qiang Lu; Chuhui Zeng; Di Chang; Shenghong Ju
Journal:  Quant Imaging Med Surg       Date:  2018-07

9.  Coronary heart disease is associated with nonalcoholic fatty liver disease in patients without hypertension and diabetes.

Authors:  Zipeng Liu; Rufeng Wei; Yan Li
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

10.  Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights.

Authors:  Justin Lee; Navneet Sharma; Farnam Kazi; Irini Youssef; Alyson Myers; Jonathan D Marmur; Moro O Salifu; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2017-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.